-
Mashup Score: 0Half of Cancer Patients Lost Neutralizing Antibodies 6 Months After COVID-19 Vaccination - 2 year(s) ago
Roughly half of patients with hematologic cancers or solid tumors lost neutralizing antibody responses to SARS-CoV-2 variants of concern at 6 months after vaccination.
Source: Cancer Therapy AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 43A blood marker predicts who gets ‘breakthrough’ COVID - 3 year(s) ago
Real-world evidence from a medical centre links high levels of potent antibodies after vaccination to a reduced risk of infection.
Source: www.nature.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Interpreting Diagnostic Tests for SARS-CoV-2 - 4 year(s) ago
This Viewpoint discusses the 2 most common categories of testing to diagnose SARS-CoV-2—real-time PCR to identify viral RNA and serological diagnosis of IgG and IgM antibodies to assess immune response—and estimates time intervals for test positivity by specimen source to help clinicians interpret…
Source: jamanetwork.comCategories: Healthcare Professionals, Latest HeadlinesTweet
SARS-CoV-2 neutralizing antibodies (nAbs) decrease substantially 6 months after COVID-19 vaccination, particularly in patients with cancer, according to a study published in @JAMAOnc. https://t.co/XoMR4d5cdi #CancerPatients #NeutralizingAntibodies